SWISX Top Holdings & Constituents
SWISX, offered by Charles Schwab, holds 694 reported positions across $14.6B in assets. Its largest holdings are ASML Holding NV (2.58%), HSBC Holdings PLC (1.46%), and AstraZeneca PLC (1.35%). The 5 biggest positions account for 8.01% of reported assets. The table below lists every reported holding with its portfolio weight and market value in US dollars — open any constituent to research its own performance.
| Position | Weight | Market Value |
|---|---|---|
— ASML Holding NV | 2.58% | $361.26M |
— HSBC Holdings PLC | 1.46% | $203.57M |
— AstraZeneca PLC | 1.35% | $189.48M |
— Roche Holding AG | 1.32% | $184.43M |
— Novartis AG | 1.29% | $180.98M |
Holdings data comes from the latest SEC Form N-PORT-P filing for this fund, covering the reporting period ended Apr 30, 2026. Market values are reported in US dollars, and each weight represents the position's share of reported fund assets. Cash, derivatives, and rounding can mean displayed weights do not total 100%. Funds rebalance and file on a schedule, so this page may not reflect intraday or post-filing changes.